Abstract: . . .  thrombosis occurs in these patients. Finally it is very important to predict for whom and when thrombosis may occur. In general, anti-cardiolipin antibody (aCL) (one kind and representative antibody of anti-phospholipid antibodies) has a significant relation to thrombosis . Especially IgG type aCL (aCL IgG) is believed to be strong indicator of thrombosis . In addition, other antibodies such as aCL IgM, aCL . . .
. . .  higher rates of thrombosis than those who lack those antibodies in APS patients, it implies an important message to the clinicians, which she also mentioned other possibilities of thrombosis without aCL antibodies later. Sequential analysis did not show interesting results including her report. It might be difficult to predict the time of thrombosis not after but prior data. Boulicaut et al applied delta-strong . . .
. . .  but less stubbornness to their medicine might be very important to succeed in this field. In medicine, EBM and prospective studies are strongly emphasized currently. Even this trial is a retrospective approach and the data are not arranged well with many noises, I have confidence that we will obtain a lot of significant evidence from the data mining techniques.  . . .
. . .  which she also mentioned other possibilities of thrombosis without aCL antibodies later. Sequential analysis did not show interesting results including her report. It might be difficult to predict the time of thrombosis not after but prior data. Boulicaut et al applied delta-strong classification rules for predicting collagen diseases. Though they extracted a lot of rules with 100% confidence, most of them are . . .
--1757,4,220,2011,8783